News

It has long been evident that labelling people with diabetes as having either type 1 or type 2 does not reflect the complexity of the condition. A paper in a recent issue of Diabetologia reviews evidence fro...

A real-world study of people with type 1 diabetes in Scotland, reported in a recent issue of Diabetologia, shows that adopting flash monitoring reduces HbA1c, as well as hospital admissions for diabetic keto...

Weight loss – an important goal for those with or at risk of type 2 diabetes – is high on many people’s list of New Year’s resolutions. For those wanting to lose weight in 2022, a new...

A long-established treatment for gout, colchicine – the world’s oldest anti-inflammatory drug – can attack COVID-19 inflammation at several points and has shown promising results in a clini...

To date, most genetic studies in type 2 diabetes have been limited to people of European ancestry, even though the increasing prevalence of the condition is set to hit low- to middle-income countries hardest...

As insulin’s centennial year draws to a close, Professor Chantal Mathieu asks what the future holds for medical history’s ‘miracle cure’ – and who might still have cause to cele...

Second-generation people of South Asian and African Caribbean ancestry born in the UK have a lower risk of type 2 diabetes than their parents, as do those of mixed heritage, according to a new study publishe...

Hyperosmolar hyperglycaemic syndrome (HHS) is associated with four- to five-fold higher mortality than diabetic ketoacidosis, yet the condition is still poorly understood. Professors Guillermo Umpierrez and ...

Just over two years after its approval in the UK and EU as the first new treatment for type 1 diabetes since the discovery of insulin, the use of dapagliflozin is no longer authorised in this population grou...

Are you a junior doctor interested in research? Have you just started your research fellowship? Do you need training in clinical research design and analysis?

In the latest in our new series, ‘Insulin in my country’, we learn about the challenges of treating diabetes in St Lucia.

Dr Kenneth Cusi, chief of the division of endocrinology and diabetes at the University of Florida and Professor Gianluca Perseghin, chief of endocrinology at the University of Milano-Bicocca, team up to disc...

To kick off its latest initiative, ‘The briefing room’, EASD e-Learning has brought together a stellar panel to discuss one of the most urgent and significant issues facing diabetes today: obesity.

In the wake of the diabetes pandemic, prevalence of non-alcoholic fatty liver disease (NAFLD) is on the rise. Following his first module about the epidemiology, pathophysiology and diagnosis of NAFLD, Profes...

Quality screening, early diagnosis and timely referrals are key to preventing amputations in diabetes. Two experts shared their knowledge in an enlightening Primary Care Diabetes Europe webinar

Professors Miles Fisher and Mike Riddell – both of whom are keen advocates of exercise for people with type 1 diabetes, and cycling aficionados – gear up and don the lycra for the latest in our s...

It’s not the most glamorous of nutrients but it’s making a big comeback in research into non-infectious diseases, including diabetes.

Psychosocial factors have profound effects on the way people live with diabetes, but how can we apply findings from behavioural research to diabetes care? Two insightful, eye-opening presentations at the 202...

Do recent studies showing unprecedented success for weight loss-inducing medications spell an end for surgical interventions to treat obesity and type 2 diabetes? Far from it, say Professor Carel Le Roux and...

Semaglutide shows promise as an obesity treatment yet again, but this time in people with type 2 diabetes

Nearly all ulcers are preventable, which is why foot care and education is such a vital part of looking after diabetes patients – and took centre stage at one of the sessions of this year’s Diabe...